HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jay S Loeffler Selected Research

Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation)

6/2016De novo development of a cerebral arteriovenous malformation following radiation therapy: Case report and an update to classical arteriovenous malformation nomenclature.
6/2014Single-fraction proton beam stereotactic radiosurgery for cerebral arteriovenous malformations.
4/2014Proton beam stereotactic radiosurgery for pediatric cerebral arteriovenous malformations.
6/2012Planned two-fraction proton beam stereotactic radiosurgery for high-risk inoperable cerebral arteriovenous malformations.
8/2003Dose-volume prediction of radiation-related complications after proton beam radiosurgery for cerebral arteriovenous malformations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jay S Loeffler Research Topics

Disease

57Neoplasms (Cancer)
12/2021 - 01/2002
29Brain Neoplasms (Brain Tumor)
01/2020 - 11/2004
19Meningioma (Meningiomas)
01/2021 - 01/2007
16Glioma (Gliomas)
01/2020 - 02/2002
16Glioblastoma (Glioblastoma Multiforme)
03/2019 - 01/2002
9Acoustic Neuroma (Acoustic Neurinoma)
01/2022 - 09/2002
8Neoplasm Metastasis (Metastasis)
01/2022 - 07/2007
7Pituitary Neoplasms (Pituitary Adenoma)
03/2018 - 04/2005
5Intracranial Arteriovenous Malformations (Cerebral Arteriovenous Malformation)
06/2016 - 08/2003
5Adenoma (Adenomas)
01/2014 - 04/2005
4Breast Neoplasms (Breast Cancer)
03/2021 - 03/2005
4Hypopituitarism (Sheehan's Syndrome)
05/2019 - 04/2005
3Hemorrhage
04/2014 - 09/2002
3Edema (Dropsy)
01/2010 - 01/2007
2Medulloblastoma
12/2022 - 01/2021
2Seizures (Absence Seizure)
01/2022 - 06/2016
2Disease Progression
03/2021 - 02/2012
2Carcinoma (Carcinomatosis)
03/2018 - 10/2013
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2015 - 01/2010
2Neurofibromatosis 2 (Neurofibromatosis Type II)
09/2010 - 05/2009
2Hypertension (High Blood Pressure)
06/2009 - 01/2002
2Acromegaly
03/2008 - 11/2007
1Neuralgia (Stump Neuralgia)
01/2022
1Facial Paralysis (Facial Palsy)
12/2021
1Dizziness (Lightheadedness)
12/2021
1Trigeminal Neuralgia (Tic Douloureux)
12/2021
1Hearing Loss (Hearing Impairment)
12/2021
1Hypoxia (Hypoxemia)
03/2021
1Nasopharyngeal Carcinoma
01/2021
1Lymphopenia (Lymphocytopenia)
01/2021
1Paraganglioma (Paragangliomas)
01/2020
1Necrosis
01/2020
1Central Nervous System Cysts (Suprasellar Cyst)
01/2020
1Wounds and Injuries (Trauma)
11/2019
1Wound Infection (Wound Infections)
11/2019
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
05/2019
1Hypothyroidism
05/2019
1Neurobehavioral Manifestations
01/2019
1Neurocytoma
09/2018
1Arteriovenous Malformations (Arteriovenous Malformation)
06/2016
1Ependymoma
06/2016
1Astrocytoma (Pilocytic Astrocytoma)
01/2016
1Demyelinating Diseases (Demyelinating Disease)
08/2015
1Cognitive Dysfunction
07/2014
1Supratentorial Neoplasms
12/2013
1Oligodendroglioma
09/2013
1Optic Nerve Diseases (Optic Neuropathy)
06/2013

Drug/Important Bio-Agent (IBA)

30Protons (Proton)IBA
01/2022 - 06/2002
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2015 - 01/2006
6Temozolomide (Temodar)FDA LinkGeneric
01/2020 - 08/2006
4Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2015 - 01/2006
4ErbB Receptors (EGF Receptor)IBA
01/2010 - 01/2002
3cediranib (AZD2171)IBA
11/2013 - 01/2007
3Tyrosine Kinase InhibitorsIBA
06/2010 - 01/2006
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2010 - 06/2006
2Immune Checkpoint InhibitorsIBA
12/2019 - 01/2018
2Growth Hormone (Somatotropin)IBA
05/2019 - 03/2008
2Biomarkers (Surrogate Marker)IBA
11/2013 - 06/2009
2IonsIBA
07/2013 - 01/2010
2SteroidsIBA
06/2010 - 01/2010
2CollagenIBA
06/2009 - 01/2002
2DNA (Deoxyribonucleic Acid)IBA
08/2008 - 08/2006
2Proteins (Proteins, Gene)FDA Link
08/2006 - 02/2002
2Methotrexate (Mexate)FDA LinkGeneric
03/2006 - 03/2005
2Trastuzumab (Herceptin)FDA Link
06/2005 - 03/2005
1Angiotensin Receptor AntagonistsIBA
03/2021
1pimonidazoleIBA
03/2021
1Losartan (Cozaar)FDA LinkGeneric
03/2021
1Lomustine (CCNU)FDA Link
01/2020
1Vincristine (Oncovin)FDA LinkGeneric
01/2020
1Procarbazine (Matulane)FDA Link
01/2020
1CTLA-4 AntigenIBA
01/2018
1B7-H1 AntigenIBA
01/2018
1Programmed Cell Death 1 ReceptorIBA
01/2018
1Histones (Histone)IBA
01/2016
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
11/2014
1RNA (Ribonucleic Acid)IBA
11/2014
1Placenta Growth FactorIBA
11/2013
1Protective AgentsIBA
10/2013
1Radiation-Sensitizing AgentsIBA
10/2013

Therapy/Procedure

66Radiotherapy
01/2022 - 01/2002
29Therapeutics
12/2021 - 01/2002
20Drug Therapy (Chemotherapy)
01/2020 - 08/2002
9Proton Therapy
12/2021 - 11/2006
5Aftercare (After-Treatment)
05/2019 - 09/2003
4Salvage Therapy
12/2021 - 03/2005
4Cranial Irradiation
05/2019 - 11/2004
2Combined Modality Therapy
12/2022 - 08/2002
2Adjuvant Radiotherapy
01/2020 - 01/2016
2Immunotherapy
12/2019 - 01/2018
2Brachytherapy
11/2019 - 09/2015
2Conformal Radiotherapy
07/2012 - 11/2009
2Retreatment
02/2012 - 01/2010
2Craniotomy
09/2003 - 09/2002
1Immunomodulation
01/2022
1Length of Stay
03/2019
1Lasers (Laser)
01/2018
1Transplantation
01/2018
1Lab-On-A-Chip Devices
11/2014
1Re-Irradiation
02/2012